AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD.
The item "Cash-Flow-Per-Share" stands at 9.78 United States Dollars as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of AstraZeneca PLC's third quarter, the item "Cash Flow Per Share" stands at 9.78 USD. This represents an increase of 15.21 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 35.48 percent compared to the value the year prior.
The 1 year change in percent is 35.48.
The 3 year change in percent is 72.76.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash Flow Per Share | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash Flow Per Share | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Flow Per Share | 399,570,305,024.00 |
![]() | Roche Holding AG - Cash Flow Per Share | 317,433,206,677.55 |
![]() | Novartis AG - Cash Flow Per Share | 255,096,620,580.91 |